Djalonensone

CAS No. 23452-05-3

Djalonensone ( Alternariol monomethyl ether )

Catalog No. M29281 CAS No. 23452-05-3

Alternariol monomethyl ether, an Alternaria toxin, is a strong mutagen in Escherichia coli strain ND-160. Alternariol monomethyl ether has genotoxic properties, it can cause oxidative DNA damage. It also possesses cytotoxic and immunosuppressive properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1618 Get Quote
10MG 2423 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Djalonensone
  • Note
    Research use only, not for human use.
  • Brief Description
    Alternariol monomethyl ether, an Alternaria toxin, is a strong mutagen in Escherichia coli strain ND-160. Alternariol monomethyl ether has genotoxic properties, it can cause oxidative DNA damage. It also possesses cytotoxic and immunosuppressive properties.
  • Description
    Alternariol monomethyl ether, an Alternaria toxin, is a strong mutagen in Escherichia coli strain ND-160. Alternariol monomethyl ether has genotoxic properties, it can cause oxidative DNA damage. It also possesses cytotoxic and immunosuppressive properties.
  • Synonyms
    Alternariol monomethyl ether
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23452-05-3
  • Formula Weight
    272.3
  • Molecular Formula
    C15H12O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc(O)c2c(c1)c1c(C)cc(O)cc1oc2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • γ-Decalactone

    γ-Decalactone is a natural compound.

  • m-PEG2-Br

    m-PEG2-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • N-Carbethoxy-4-piper...

    Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals.